Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American

Latin American Cooperative Oncology Group (LACOG)

Status: Completed

Conditions: Kidney Neoplasms

Treatments: Other: Observational study

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05184504

LACOG 1120

Details and patient eligibility

About

Observational study, retrospective and prospective, of an analytical nature. Data will be collected from medical records and/or through contact with physicians and institutions (secondary data collection). Patients included retrospectively or prospectively will be followed during the data collection period for the evaluation of treatments and survival. No intervention is planned in this protocol.

Enrollment: 211 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients ≥ 18 years of age;
• Proven histology of renal cell carcinoma (any subtype);
• Pathological diagnosis of renal cell carcinoma in January 2015 or later and new cases diagnosed during the period of recruitment of each center;
• Have the medical record available and suitable for collecting data on patient characteristics, treatment and outcome.

Exclusion criteria

• Synchronous or other primary tumor within the last 3 years (except thyroid cancer or non melanoma skin).

Trial design

211 participants in 1 patient group

Patients with pathological diagnosis of renal cell carcinoma

Description:

Patients aged 18 years or older, who have been diagnosed with renal cell carcinoma (new case or recurrence) since January 2015 and during the study recruitment period.

Treatment:

Other: Observational study